Podcasts about Prostate cancer

In this Huberman Lab Essentials episode, my guest is Dr. Kyle Gillett, MD, a dual board-certified physician in family medicine and obesity medicine and an expert in optimizing hormone levels to improve overall health. We explain how to improve hormone levels across the lifespan in both men and women using behavioral, nutritional and exercise-based tools. We also discuss common clinical topics, including hormone testing, PCOS, hair loss, testosterone replacement therapy (TRT) and peptides, focusing on potential benefits, tradeoffs and risks. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Maui Nui: https://mauinuivenison.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Kyle Gillett (00:00:36) Hormone Health; Women vs Men, Tool: Hormone Testing (00:02:35) Tool: Big 6 Lifestyle Pillars to Optimize Hormone Health (00:04:32) Sponsor: AG1 (00:06:17) Diet, Individualization; Bloodwork & Frequency (00:07:20) Exercise, Zone 2 Cardio; Caloric Restriction (00:08:36) Intermittent Fasting, Growth Hormone, IGF-1 (00:11:05) Hormones & Sleep, Growth Hormone, Menopause, Andropause, TRT (00:13:28) Testosterone & Women, SHGB (00:15:19) Sponsor: Maui Nui (00:16:34) Dihydrotestosterone (DHT), Androgens; Turmeric & Black Pepper; Hair Loss (00:19:47) Polycystic Ovarian Syndrome (PCOS), Symptoms, Metformin, Inositol (00:23:13) Cannabis, Alcohol, Testosterone (00:24:48) Males & Testosterone, TRT, Prostate Cancer (00:26:04) Prolactin, Dopamine "Wave Pool", Tool: Casein & Gluten (00:27:23) Sponsor: Function (00:29:03) Social Relationships & Hormones, Tool: Planning for Crisis (00:31:02) Peptides, Growth Hormone & Risk; BPC 157, Sourcing & LPS (00:36:42) Melanotan, Uses & Risks (00:38:45) Spiritual Health, Interdisciplinary Health Integration (00:41:23) Caffeine & Hormones, Sleep; Acknowledgements Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Silke details the 2025 prostate cancer highlights

Send us a textSeason 3 Episode 17Welcome back to Who's Tom & Dick. In this episode, Patrick and Martin finally sit down together for a proper catch-up since Martin's return home from hospital. It's a conversation that's been a long time coming — honest, unfiltered, and rooted in real life.Martin shares how the past days have been since coming home: the small wins, the ongoing challenges, and what recovery actually looks like away from the hospital ward. Patrick and Martin reflect on the physical and emotional realities of navigating long-term and life-changing health conditions, speaking openly about Multiple Sclerosis, Arthritis, Strokes, and Prostate Cancer — topics that affect so many families, yet are still too often whispered about or avoided altogether.This episode isn't about medical jargon or scare stories. It's about lived experience, resilience, and the importance of talking — properly talking — about health, vulnerability, and support. There are moments of reflection, moments of honesty, and moments where laughter becomes just as important as the conversation itself.And because it wouldn't be Who's Tom & Dick without ending on a high, the episode wraps up with a bit of festive warmth, Christmas cheer, and the return of a firm favourite… Martin's Joke of the Week — proving once again that even in the face of serious challenges, humour still has its place.So make yourself comfortable, grab a brew, and join us for a heartfelt, hopeful, and very Who's Tom & Dick Christmas catch-up.www.whostomanddick.com#HeartTransplant#eatingdisorder#RareCondition#HealthJourney#LifeChangingDiagnosis#MentalHealth#Vulnerability#SelfCompassion#PostTraumaticGrowth#MedicalMiracle#BBCSports#Inspiration#Cardiology#Surgery#Podcast#Healthcare#HeartHealth#MedicalBreakthrough#EmotionalJourney#SupportSystem#HealthcareHeroes#PatientStories#CardiologyCare#MedicalJourney#LifeLessons#MentalWellness#HealthAwareness#InspirationalTalk#LivingWithIllness#RareDiseaseAwareness#SharingIsCaring#MedicalSupport#BBCReporter#HeartDisease#PodcastInterview#HealthTalk#Empowerment#Wellbeing#HealthPodcast#prostatecancer#Aid's#prostateCheck out our website at www.whostomanddick.comCheck out our website at www.whostomanddick.com

"The thought of recurrence is also a psychosocial issue for our patients. They're being monitored very closely for five years, so there's always that thought in the back of their head, 'What if the cancer comes back? What are the next steps? What am I going to do next?' It's really important that we have conversations with patients and their families about where they're at, what we're looking for, and reassure them that we'll be with them during this journey and help them through whatever next steps happen," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer survivorship considerations for nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by December 19, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to survivorship nursing considerations for people with prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 390: Prostate Cancer Treatment Considerations for Nurses Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: APRNs Collaborate With PCPs on Shared Survivorship Care Models Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors Nursing Considerations for Prostate Cancer Survivorship Care Regular Physical Activity and Healthy Diet Lower Risk of All-Cause and Cardiac Mortality in Prostate Cancer Survivors Sexual Considerations for Patients With Cancer Sleep Disturbance Is Part of a Behavioral Symptom Cluster in Prostate Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing articles: A Patient-Specific, Goal-Oriented Exercise Algorithm for Men Receiving Androgen Deprivation Therapy Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Prostate Cancer: Survivorship Care Case Study, Care Plan, and Commentaries The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: A Qualitative Exploration of Prostate Cancer Survivors Experiencing Psychological Distress: Loss of Self, Function, Connection, and Control Identification of Symptom Profiles in Prostate Cancer Survivors Sleep Hygiene Education, ReadiWatch™ Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia for People With Prostate Cancer Understanding Men's Experiences With Prostate Cancer Stigma: A Qualitative Study Other ONS resources: Late Effects of Cancer Treatment Huddle Card Survivorship Care Plan Huddle Card Survivorship Learning Library American Cancer Society (ACS): Living as a Prostate Cancer Survivor ACS prostate cancer survivorship studies To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the most common late side effects [are] urinary, bowel, and sexual dysfunction issues. For urinary effects, it can include urgency and frequency, some incontinence, or a weak or slow urine stream that frequently bothers the patient after treatment. Bowel effects can happen such as constipation, diarrhea, or inflammation of the rectum, which can lead to bleeding or mucus discharge. And then erectile dysfunction is another side effect that patients with prostate cancer often deal with and have to work with their physicians on, depending on what they want with that function. Fatigue, lymphedema, and skin changes can also occur after treatment." TS 1:40 "If we can catch [prostate cancer] and take care of it at an early stage, overall survival is about 90%. If the disease is localized, it's 99%. If we can take out the prostate, radiate the prostate, we can do something with that—localized, 99% survival rate. If there's regional metastasis, it's about 90%. And if there's distant metastasis, it's about 30% survival." TS 3:55 "Prostate cancer recurs in about 20%–30% of patients within the first five years of initial treatment. ... There's not a lot of research out there that shows what can reduce risk, but what has been shown to be effective is regular exercise, quitting smoking, and eating a healthy diet. ... It's really important for our patients to understand the importance of having follow-up visits so that we can catch a recurrence quickly instead of waiting years down the road. Prostate cancer is usually a slow-growing disease, so if we can pick it up quickly in those revisits, we can start another treatment for the patient." TS 6:00 "Sexuality is not something many people are comfortable discussing, but we really need to talk with patients and let them know that this is normal. It is normal that you may have some sexual dysfunction. It's normal that you may not feel the way you did before. Talk to us about it, let us know where you're at, let us know what your goals are, because there are a lot of things we can do. There are medications we can use for impedance. There are devices and implants available to help the patient to support them and give them whatever their goal is for their sexuality." TS 9:41 "Providing survivorship care plans are important for these patients—something that can be sent off to everyone else that's caring for that patient. You have your primary care physician, urologist, oncologist, the oncology nurse, maybe a navigator, and [others] who are looking into this patient. So, giving that patient a survivor care plan and putting it with their files to include a summary of the treatment received, because most of the time a patient is not going to remember exactly what they received. A suggested schedule for follow-up exams—so again, if a primary care provider is not used to dealing with a patient with prostate cancer, they have something to go off of. A schedule of other tests they may need in the future including screening for other types of cancer. Are they a smoker? Do they need lung screening? Do they need any other screenings related to types of cancers? And then a list of possible late or long-term side effects." TS 15:16 "I think a lot of people know about the long-term sexual effects, but what we don't really talk about is the effect that it has on the patient's self-image. How they define themselves, how they look, their body image, their self-image. It's really important that we continue to discuss it with patients and make them comfortable when discussing their sexuality and their goals for sexuality. They may be having these self-image issues after treatment that they're just not telling us about and that can affect their quality of life." TS 18:38

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics: Introduction (0:00) Prostate Cancer (1:44) Urothelial Bladder Cancer (29:18) CME information and select publications

Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center and Dr Rana R McKay from the UC San Diego Moores Cancer Center summarize the treatment landscape for prostate and urothelial bladder cancer and discuss the implications of clinical findings recently presented at the ESMO Congress 2025.CME information and select publications here.

Fear can turn even measured men into urgent patients and nowhere is that more obvious than in prostate cancer treatment. In this episode, Dr. Stephen Petteruti addresses this fear-driven reflex, reminding men that clarity comes not from panic, but from understanding how the system often uses fear to push unnecessary interventions. He exposes why biopsies, radiation, surgery, and castration therapies are recommended far more often than they are needed. Dr. Stephen explains how medical bias guides many of these decisions, and he highlights major studies like PIVOT and ProtecT trials that show most aggressive treatments don't improve survival, but they do harm vitality and long‑term health. He also breaks down how urgency is manufactured. Prostate cancer is rarely an emergency, and men almost always have time to think, ask questions, and explore options.For anyone sensing pressure to act fast, this episode offers a clear perspective. Tune in here: How Fear Sells Prostate Cancer Treatment.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In Episode 100, Jamie and Matt reflect on a year that fundamentally reshaped how Matt experiences healthcare—as both a patient and a caregiver. Matt shares an update on his active surveillance prostate cancer journey, including lifestyle changes, monitoring, and learning to live with uncertainty.The conversation expands beyond Matt's diagnosis to include the realities of caregiving: navigating a father's dementia and hospice journey, processing anticipatory grief and loss, supporting a teenage daughter through surgery, and helping a mother recover after a stroke. Matt speaks candidly about caregiver burnout, moments of emotional paralysis, and the importance of asking for help.Together, Jamie and Matt explore how grief lingers, how recovery often proves harder than the crisis itself, and why healthcare must focus on what happens after discharge. Episode 100 closes with a powerful reminder: it's okay not to be okay—but it's not okay to face it alone.

Note: This episodes contains discussion and language of a sexual nature and may not be appropriate for all audiences.In this episode of Marrow Masters, we sit down with Dr. Christian Nelson, a psychologist at Memorial Sloan Kettering Cancer Center and an expert in psycho-oncology, to address a deeply personal yet often overlooked topic: male sexual dysfunction following cancer treatment. Together, we explore how treatments can impact not only physical function but emotional well-being, identity, and relationships.We start by acknowledging that sexual dysfunction is one of the most common side effects of cancer treatment, second only to fatigue. Yet, it's rarely discussed. Dr. Nelson emphasizes the importance of normalizing the conversation and encouraging patients to raise the issue with their treatment teams. He walks us through the emotional toll that erectile dysfunction can take on men, noting how it strikes at the core of masculinity and can lead to increased depression, frustration, and a general sense of brokenness. He stresses that it's not just about what happens in the bedroom—erectile issues can spill over into all aspects of a man's life, including his relationship with his partner.Dr. Nelson outlines a range of treatment options, from well-known medications like Viagra to lesser-known but effective methods like penile injections and implants. He breaks down the fear around these options, especially injections, and highlights how pain levels are often far lower than anticipated. Beyond physical treatments, we discuss the emotional and relational work that's often required. One key issue is avoidance—men avoiding sexual situations due to performance anxiety, which can snowball into long-term distance and silence between partners. Dr. Nelson makes it clear: the real risk isn't failure, it's not trying.We also dive into how couples can redefine intimacy. Many men associate sex solely with penetration, while their partners often value closeness and emotional connection more. Dr. Nelson advocates for expanding the sexual repertoire and restoring non-sexual forms of affection, which can be just as meaningful. We talk about the impact of testosterone—how its depletion can lower libido and cause men to unknowingly withdraw from their partners—and how testosterone replacement may be a viable option for some, depending on cancer type and treatment history.As roles shift from caregiver back to partner post-treatment, Dr. Nelson stresses the importance of open communication. He urges couples to work toward understanding each other's perspectives, not convincing each other. He shares an "aha" moment involving a couple who waited five years before seeking help, only to reconnect within three sessions after simply opening the lines of communication. The takeaway: don't wait.We close by pointing listeners toward additional resources, including certified sex therapists and specialized urologists, and Dr. Nelson highlights two key professional directories: SSTAR and AASECT. We're reminded that even the simplest questions—like whether it's okay to kiss your partner—deserve answers. It's on all of us, both patients and providers, to make room for these conversations.More:Episode with Dr. Flores: https://marrowmasters.simplecast.com/episodes/mens-sexual-health-gvhdEpisode with Dr. El Jawahri: https://marrowmasters.simplecast.com/episodes/dr-el-jawahriSSTAR (Society for Sex Therapy and Research) – https://sstarnet.orgAASECT (American Association of Sexuality Educators, Counselors and Therapists) – https://www.aasect.orgThanks to our Season 19 sponsors, Incyte and Sanofi.https://incyte.com/https://www.sanofi.com/en00:00 - Introduction to Season 19 and Dr. Christian Nelson  01:16 - Normalizing Conversations on Sexual Dysfunction  04:50 - Emotional Toll of Erectile Dysfunction  07:06 - Treatments: Pills, Injections, and Implants  09:03 - Avoidance and Anxiety in Sexual Relationships  12:17 - Expanding the Definition of Intimacy  16:43 - Role of Testosterone in Sexual Health  20:05 - Shifting from Caregiver to Partner  22:17 - Resources and Where to Get Help  26:29 - A Patient Story: Five Years of Silence  28:07 - Closing Thoughts and Resources   National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.To participate in the GVHD Mosaic, click here: https://amp.livemosaics.com/gvhd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Brian Crombie is joined by Dr. Anna Wilkinson, a family physician with a special interest in oncology and an Associate Professor at the University of Ottawa, for a timely and evidence-based conversation about prostate cancer screening — and why current approaches may need to change. Dr. Wilkinson bridges primary care and oncology, studying how screening guidelines translate into real-world outcomes. In this episode, she explains why prostate cancer screening today looks very different than it did decades ago, and why outdated assumptions may be contributing to rising rates of advanced, incurable disease.Topics discussed include:

A longer, stronger life often begins with one intentional step. Yet the simplest habits are the ones we underestimate most. In this episode, Dr. Stephen Petteruti highlights one remarkable practice that research links to a 61% reduction in prostate cancer mortality rooted in longevity, practicality, and everyday discipline. He walks listeners through the science behind this habit: three hours per week of vigorous walking. He explains how the right type and duration of movement supports immune function, slows cancer progression, and enhances overall vitality. He also breaks down why extreme exercise backfires, why muscle mass and protein intake matter more than people think, and how simple resistance training can strengthen the body's defenses.He offers guidance on how men can maintain strength, confidence, and energy even when navigating elevated PSA levels or prostate cancer diagnoses.Take a moment for your future health and put these principles to work for your longevity. Watch the episode of One Habit That Cuts Prostate Cancer Death Risk by 61%.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Commentary by Dr. Eric Yang.

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/   Dr. Morse Q&A - Tumor - Leukemia - Vitamin C - Prostate Cancer and More #815 00:00:00 - Intro 00:00:28 - Tumor - Leukemia - Liposomal Vitamin C  00:07:40 - Stage 4 Prostate Cancer 00:00:28 - Tumor - Leukemia - Liposomal Vitamin C  Is there any circumstance where Dr Morse would recommend using Liposomal Vitamin C? 00:07:40 - Stage 4 Prostate Cancer I would like your help please, I want to know if I guided my nephew correctly.

In this episode, Ashutosh (Ash) K. Tewari, MD, Urologist and Prostate Cancer Specialist and Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai, discusses the rise in prostate cancer cases, strategies to reduce treatment-related side effects, and how mobile units are expanding outreach to improve patient access and early detection.

Late-stage prostate cancer diagnoses are on the rise in Canada. According to a recent study, between 2010 and 2021, rates of prostate cancer discovered at Stage 4 increased by about 50 per cent in men aged 50 to 74. In men over the age of 75, rates were up over 65 per cent.There is a simple blood test that can screen for early signs of prostate cancer, called a prostate specific antigen, or PSA test; however, in 2014, Canada recommended against using the PSA for widespread screening. Today, Globe health reporter Kelly Grant explains what this study found and why these guidelines are so highly contested in Canada.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through routine screenings. This episode, we discuss risk factors for prostate cancer, how to get screened and what you can do if you are diagnosed.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through routine screenings. This episode, we discuss risk factors for prostate cancer, how to get screened and what you can do if you are diagnosed.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this episode, Dr. Ardeshir Rastinehad, Vice Chair of Urology at Northwell's Lenox Hill Hospital and System Director for Prostate Cancer at Northwell Health, discusses emerging trends and breakthroughs in prostate cancer screening, diagnosis, and treatment. He explains the focal therapy process—including cryotherapy—and shares insights on the mission and impact of the Focal Therapy Society.

The best water filter?Even more on gadoliniumVagus nerve therapy benefitsWith so many benefits of drinking coffee, should I drink more of it instead of tea?Any update on Barrett's Esophagus?

Nutritional strategies for treating Barrett's EsophagusHow can my uncle mitigate the side effects of his Merkel cell carcinoma therapy?How long can I take strontium?Is beet root powder beneficial for nitric oxide production?

In this bonus episode of 20-Minute Health Talk, host Sandra Lindsay speaks with filmmaker Richard LaRochelle, who also works with Northwell's community health program. LaRochelle filmed a conversation with four prostate cancer survivors, including former New York Knicks player Allan Houston, with the goal of raising awareness about prostate cancer among the black community. LaRochelle shares his experience in making the short film and what he hopes audiences will learn from the men's experiences.  View The Unspoken Truth: A Dialogue on Prostate Cancer Among Black Men. This bonus episode is Part 4 of this series. Listen to Part 1  Listen to Part 2  Listen to Part 3 About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. It's the second-leading cause of cancer-related death for American men, behind lung cancer, according to the American Cancer Society.Wednesday on Midday Edition, we invite Jerry McCormick to tell the story of his own diagnosis and his efforts to spread awareness of the disease.Then, we get a medical perspective on prostate cancer, from getting screened to available treatments.Guests:Jerry McCormick, prostate cancer awareness advocateDr. Ramdev Konijeti, director of the Genitourinary Oncology Program at Scripps Cancer Center, surgeon with Scripps Clinic

On this episode host Jonathan Chance talks about the silent killer men avoid talking about, Prostate Cancer. This episode hits close to home for Jonathan because all this silence among men nearly cost him his life. On this episode Jonathan talks about:·       Why men don't talk about prostate cancer. ·       The lifesaving importance to end this silence.·       How prostate cancer awareness can help save lives.·       A call to action for men to start the conversation about prostate cancer.Prostate Cancer Aware is grateful to the Jevan and Ruzanna Chimayan Foundation for their generous donation, which will help fuel our podcast to raise critical awareness about prostate cancer and the PSA test around the world.Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer. Visit our website at: https://www.iknowmypsa.org Email us at: https://www.iknowmypsa.org/contactus/ Follow Prostate Cancer Aware on social media at: Facebook - https://www.facebook.com/iknowmypsa Twitter - https://twitter.com/iknowmypsa or @iknowmypsa Thank you for listening! Remember, Stay Aware and Stay Healthy.™

YouTube star Funky Dineva's prostate cancer diagnosis stopped us in our tracks. We're talking about why his brave story is a powerful lesson in catching health issues early and what “Stage 1” actually means for recovery. Then we'll look at that Campbell Soup executive's comment about “food for poor people” and unpack the bigger issue of how income shapes the way we eat. We'll also take a deeper dive into Donald Glover's stroke at 42 and find out what a “hole in the heart” really is. Plus, norovirus cases are doubling across the country and we'll help you stay safe. And if your brain's been feeling foggy after scrolling TikTok or Instagram, you're not imagining it.This podcast is intended to be informational only.  It is not a medical consultation, nor is it personalized medical advice.  For medical advice, please consult your physician.#HealthHappyLifePodcast #DrFrita #MedicalMondays #CelebrityHealthNews #MedicineInTheNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

Another of our special Themed Podcasts focussed on prostate cancer in China, supported by our Gold Partner, Bayer. We are joined as ever by our China Editor, Dr Yao Zhu (Fudan University Shanghai Cancer Centre), and also special guest Dr Yige Bao (SCU Xiamen Hospital). Not only do we learn about pandas in West China, but also some great highlights from the recent ESMO Annual Meeting in Berlin! Hosted as ever by Dr Renu Eapen and Prof Declan MurphyEven better on our YouTube channel 

In this episode of 20 Minute Health Talk, host Sandra Lindsay delves into the emotional journey of prostate cancer from the unique perspectives of supportive partners. Joining her are two remarkable women, Mary Hillery and Tamara Houston, who share their experiences as caregivers alongside their husbands, prostate cancer survivors Tony Hillery and former New York Knicks player Allan Houston. Mary Hillery, a human resources expert, offers insights on resilience and caregiving. Tamara Houston, an educator and advocate for youth empowerment, speaks on the power of faith and familial support in challenging times.  This is Part 3 of this series. Listen to Part 1  Listen to Part 2  About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities.   Facebook –   / northwellhealth   Instagram -   / northwellhealth   X - https://www.x.com/northwellhealth LinkedIn - https://www.linkedin/northwellhealth

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, and host of the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. 

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, licensed acupuncturist, and certified Functional Medicine practitioner, discusses prostate health, including the latest advances in prostate cancer treatment and the importance of a balanced approach between natural and conventional medicine. Dr. Espinosa also highlights the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. The conversation covers PSA testing, new diagnostic tools, advanced treatment options like androgen deprivation therapy, and the benefits of exercise and diet in managing prostate health.

A prostate cancer support group in Ardnacrusha is offering vital help to men and their families, thanks to the work of founder Tony Bridgeman, who set it up in April 2023. Among those involved is Phelim Warren, a cancer survivor whose own diagnosis came as a shock despite having no symptoms. His story highlights the importance of regular blood tests, early detection and open conversations around men's health. To find out more, Alan Morissey was joined by Tony Bridgeman and Pheilim Warren on Tuesday's Morning Focus. Join the prostate cancer support group here: https://www.facebook.com/groups/1380816599365491 Photo: (c) Clare fm/ Pheilim Warren/ logo from Prostate Cancer Support Group Ireland via Facebook.

Today, we'll be tackling the future of prostate cancer care. We'll be reflecting on what prostate cancer care means in practice, how the way we think about the disease is shifting, and must continue to shift in the years ahead. Scientific advances have transformed treatment in recent years, yet the lived reality of prostate cancer still extends far beyond the clinic. The disease reshapes daily life, and may leave men and their families grappling with difficult choices about how best to manage it.  Dr. Güneş Taylor is joined by three key voices at the centre of this story, following the prostate cancer journey from diagnosis through to long-term management, and asking how patients and clinicians can work together to re-think what patient-centred care could mean in the years to come. This episode is brought to you in collaboration with Bayer, part of their Prostate Cancer Perspectives series.  PP-UN-ONC-GB-0168. November 2025 References Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263 (Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide) James D, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683–1722 (Each year, around 1.5 million men are diagnosed and nearly 400,000 lose their lives to the disease.1 And the numbers are rising. Diagnoses are projected to double from 1.4 million annually in 2020 to 2.9 million by 2040) Siegel RL, et al. Cancer statistics, 2022. Ca Cancer J Clin. 2022;72:7–33 (In the U.S., the proportion of men diagnosed with advanced-stage prostate cancer has doubled in recent years, due to increasing incidence of advanced-stage disease and changing guidelines regarding the prostate specific antigen screening test, implemented in the U.S. in 2012) Dodkins J, et al. Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population based evaluation. BMJ Oncology. 2025;4:e000643 (In England, nearly one in five men only receive a diagnosis once their cancer has spread) Calvo-Schimmel A, et al. Supportive care interventions and quality of life in advanced disease prostate cancer survivors: An integrative review of the literature. Can Oncol Nurs J. 2021;31(4):412-429 (Advanced prostate cancer is often associated with long-term challenges leading to greater levels of unmet needs in supportive care) Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this week's news podcast, the former UK prime minister, David Cameron, calls for prostate cancer screening following his diagnosis. But does it really help to know you have the disease? Also, we find out about the DNA composition of the carbon-rich asteroid Bennu, the underlying cause of Santorini's recent earthquakes, and scientists discover where domestic cats came from... Like this podcast? Please help us by supporting the Naked Scientists

A panel of experts has recommended that screening for prostate cancer should be targeted only at men who are most at risk of developing the disease. Also: Downing Street has denied allegations that the Chancellor, Rachel Reeves, misled the public over the state of public finances in the run up to this week's Budget. And the UK has launched a bid to host the 2035 Women's World Cup, with 22 stadiums across the country potentially eligible.

One of Australia’s best-known and most colourful politicians, Barnaby Joyce, is quitting the National Party to sit as an independent—and he hasn't ruled out joining Pauline Hanson’s One Nation in the future. Sarah Ison joins Claire Harvey to unpack the shock defection, what Pauline Hanson sees in the firebrand former leader, and why Joyce isn't resigning his New England seat to trigger a by-election. Read more about this story, plus see photos, videos and additional reporting, on the website or on The Australian’s app. This episode of The Front is presented and produced by Claire Harvey and edited by Tiffany Dimmack. Our team includes Kristen Amiet, Lia Tsamoglou, Tiffany Dimmack, Joshua Burton, Stephanie Coombes and Jasper Leak, who also composed our music. See omnystudio.com/listener for privacy information.

World-renowned sexual health expert, Dr Chris Nelson, Chief of Psychology at Memorial Sloan-Kettering Cancer Centre, joins us in studio to run through the new Movember-supported "Guidelines for Sexual Health Care for Prostate Cancer Patients". A really helpful overview and structure for anyone working in this field, and for patients and their loved ones. Chris shares his 20-plus years of experience working in this field at one of the world's premier prostate cancer centres.Even better on our YouTube channel  Links:Movember Sexual Health Guidelines

A bin man from Dover with terminal cancer has been escorted to his wedding by a procession of refuse trucks.Stephen Addley's been told he has just months to live and one of his final wishes was to marry his fiancée and make memories with their one-year-old daughter.Also in today's podcast, we've got reaction to yesterday's budget after the chancellor announced £26 billion of tax hikes.Rachel Reeves has insisted the financial plans she announced in the Commons were based on her priorities.She also says the measures will give working class children the chance to have a fulfilling life.Hear from Andrew Tate and Rachel Emmerson from Chatham based accountants Kreston Reeves, Chatham and Aylesford MP Tris Osborne and the CEO of Canterbury based homeless charity Porchlight.Two men involved in a violent axe attack near Canterbury have been jailed for a total of 48 years.Police were called to reports of an assault involving people in two cars on the A2 near Wincheap in December last year.A driver involved in a serious crash on the A21 has called for safety improvements to be made.Conor Hardy says his vehicle aquaplaned at 70-miles-per-hour on the Tonbridge bypass following heavy rain, due to poor drainage. He's been speaking to reporter Elli Hodgson.A Medway man with incurable prostate cancer is among those calling on the health secretary to bring in a national screening programme.More than 120 MPs have also written to Wes Streeting after former Prime Minister David Cameron revealed he was treated for the disease last year. Hear from Paul Dennington who has raised more than £155,000 for Prostate Cancer UK.And, Ashford Designer Outlet has reached full occupancy for the first time since its 90 million pound extension opened six years ago.Two new fashion brands have opened at the shopping centre. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/ 00:00:00 - Intro - Books and New Courses! 00:05:36 - Stage 4 Cancer - Prostate 00:23:17 - Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Update with Eye Pictures 00:36:50 - Severe Bone Loss - Suicidal - Depression - Loss of Self 00:05:36 - Stage 4 Cancer - Prostate Everyone was stunned as my bone structure has regenerated and they don't know how to explain it! 00:23:17 - Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Update with Eye Pictures My 19-year-old collapsed on a volleyball court while playing. 00:36:50 - Severe Bone Loss - Suicidal - Depression - Loss of Self I have always dealt with depression and teeth problems.

 JR Richardson expressed overwhelming disbelief at his cancer-free diagnosis, stating he had been mentally prepared to die and was still recalibrating his mindset about surviving for his two children aged 15 and 17.Medical misdiagnoses occurred from 2018-2021 when JR's symptoms including pressure in his taint area were attributed to a fistula, fissure, and prostatitis rather than recognizing his PSA level of 21 as a cancer indicator.Healthcare providers failed to communicate the significance of JR's PSA level of 21, simply recommending a blood test without urgency, leading to a delayed diagnosis when his PSA reached 85.6 by the time of proper testing.Oncologist provided a grim prognosis of two to five years with palliative care options including abiraterone, steroids, and hormone blockers, offering no alternative treatment choices.JR declined conventional treatment initially, having been familiar with cannabis oil since Phoenix Tears and connected with Valerie Corral from WAMM, the first cannabis cooperative in the United States.Valerie Corral was identified as the pioneer who developed the 4:1 cannabis ratio and successfully sued the federal government after a farm raid, winning her case with Santa Cruz County support.Cannabis oil treatment began with JR taking a gram of oil he had made, but Corey Yelland advised switching to 4:1 ratio rectal administration for better effectiveness.PSA levels dropped dramatically from 85.6 to 29 within one month of starting 4:1 rectal cannabis treatment, and further decreased to 3.82 after receiving one hormone injection.Continued cannabis treatment brought PSA levels to normal range, with readings of 2.33, 1.82, and stabilizing around 1.72, demonstrating sustained improvement.Stanford Medical provided a second opinion contradicting the initial oncologist's palliative approach, recommending the Stampede Study protocol with pinpoint radiation on lymph nodes and two small spinal spots.Radiation treatment decision was made after consultation with a knowledgeable technician who explained advances in precision radiation technology, addressing JR's concerns about radiation damage based on his aunt's experience.Daily cannabis dosage consisted of at least one gram of CBG orally and two grams rectally with 10-20% lipid addition, plus additional oral THC, prioritizing survival over psychoactive effects.Valerie Corral's experience indicated that long-term cancer survivors in her practice had used both Western medicine and cannabis oil, influencing JR's decision to combine treatments.Recent scan results showed no metabolically active disease in previously affected areas including nodes and spine, confirming complete remission and validating the combined treatment approach. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized" by Góes et al. published on September 10, 2025. TRANSCRIPT Natalie DelRocco: Hello and welcome to JCO Precision Oncology Article Insights. I'm your host, Natalie DelRocco, and today we will be discussing the editorial "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized." This editorial by Góes, Li, and Chehrazi-Raffle, and Janopaul-Naylor et al. describes genomic risk classifiers, or GRCs, for patients with localized prostate cancer. Like any risk prediction model, GRCs are intended to help identify groups of patients that may benefit from less intense or more intense anticancer therapy. Risk prediction tools can be difficult to bring into clinical practice; they require a lot of validation. And as the authors describe, GRCs in localized prostate cancer are no exception. The authors of this editorial contextualize an article by Janopaul-Naylor et al., which attempts to retrospectively explore the clinical use of three available GRCs for localized prostate cancer: Decipher, Oncotype DX, and Prolaris. Each of these three GRCs is being used in clinical practice currently. In the original article, all three GRCs were associated with less intense therapy being prescribed in practice. However, the editorial authors note that this is likely selection bias due to the observational nature of the study design. It is conceivable that GRCs were more likely ordered to make decisions for patients who were already thought to be good candidates for less intensive therapy. Another weakness of the retrospective study design is that patient level covariates known to be associated with clinical prognosis in localized prostate cancer, such as staging, Gleason score, prostate specific antigen, were unavailable. The authors note that sampling bias may also be an issue. Uninsured patients are not included in the original article, and therefore may impede the ability to make conclusions about the association of GRC use with income level. The editorial authors highlight important study findings as well as these limitations, such as the heterogeneity of interventions following GRC result return. The Prolaris GRC was found to be associated with more surgical interventions, while the Decipher GRC was associated with more androgen deprivation therapy plus radiation. Additionally, patients with active surveillance were more likely to have a GRC in general ordered. While these conclusions are very interesting, the editorial authors note that further exploration and validation, given the retrospective study design and limitations outlined, are needed to fully understand the impact of GRCs in the practice of treating localized prostate cancer. Thank you for listening to JCO Precision Oncology Article Insights. Don't forget to give us a rating or a review and be sure to subscribe so that you never miss an episode. You can find all ASCO shows atasco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In today's episode, we had the pleasure of speaking with Daniel Spratt, MD, chair and professor in the Department of Radiation Oncology at Case Western Reserve University School of Medicine and a member of the Case Comprehensive Cancer Center in Cleveland, Ohio. Dr Spratt discussed key updates to the National Comprehensive Cancer Network (NCCN) Guidelines for prostate cancer, including how advances in molecular imaging, evolving systemic therapy options, and the integration of next-generation androgen deprivation therapy (ADT) are reshaping treatment recommendations across localized, recurrent, and advanced disease settings.

Michael Morris from MSKCC joins us for an in-depth review of ARPI development across the spectrum of prostate caner

In this episode of Agents of Nonprofit, I speak with Laurent Proulx, CEO of PROCURE, about the urgent need for proactive prostate cancer awareness, screening, and open conversation. With honesty and clarity, Laurent reinforces that early detection saves lives—and that vulnerability, not silence, is the real strength.Topics We Cover:Why family history (including mother's breast cancer) and ethnicity significantly increase prostate cancer riskHow Laurent's own diagnosis was discovered through an unexpected insurance medical examInside Procure's $10M biobank and its exclusive research advantages in QuebecHow data from 2,000 men is helping researchers understand which cancers become aggressiveThe role of AI in shaping the future of patient education and prostate cancer supportTo Learn More and Connect with Laurent:PROCURE.caPROCURE on InstagramSupport the show

In this special session from the upcoming Prostate Summit 2.0, Dr. Eric Zielinski sits down with Dr. Geo for a rare, vulnerable and informative conversation about the why behind his life's work in prostate cancer care.Key PointsThe emotional and spiritual side of working with thousands of menWhy your why matters more than the diet, protocol, or treatment choiceThe 3 buckets of prostate cancer and why care must be personalizedHis 4 pillars of healing: lifestyle, nutrition, fitness, and stress masteryHow fasting, cruciferous veggies, mushrooms, herbs, and targeted nutraceuticals help build resilienceWhy exercise is non-negotiable, and how sitting all day harms prostate and metabolic healthThis episode blends heart, science, and practical strategy to help men live longer and better with prostate cancer.Chapters00:00 – Intro02:00 – The “why” behind Dr. Geo's work07:00 – A powerful patient story & legacy12:00 – The 3 buckets of prostate cancer18:00 – Food, fasting & “It Days”23:00 – Exercise, sitting & movement32:00 – Mushrooms, herbs & targeted nutraceuticalsFrom the upcoming Prostate Summit 2.0

"Any time the patient hears the word 'cancer,' they shut down a little bit, right? They may not hear everything that the oncologist or urologist, or whoever is talking to them about their treatment options, is saying. The oncology nurse is a great person to sit down with the patient and go over the information with them at a level they can understand a little bit more. To go over all the treatment options presented by the physician, and again, make sure that we understand their goals of care," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer treatment considerations for nurses.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 21, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 373: Biomarker Testing in Prostate Cancer Episode 324: Pharmacology 101: LHRH Antagonists and Agonists Episode 321: Pharmacology 101: CYP17 Inhibitors Episode 208: How to Have Fertility Preservation Conversations With Your Patients Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Communication Models Help Nurses Confidently Address Sexual Concerns in Patients With Cancer Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Nurses Are Key to Patients Navigating Genitourinary Cancers Sexual Considerations for Patients With Cancer The Case of the Genomics-Guided Care for Prostate Cancer ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) Clinical Journal of Oncology Nursing articles: Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Physical Activity: A Feasibility Study on Exercise in Men Newly Diagnosed With Prostate Cancer The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer Other ONS resources: Biomarker Database (refine by prostate cancer) Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse Brachytherapy Huddle Card External Beam Radiation Huddle Card Hormone Therapy Huddle Card Luteinizing Hormone-Releasing Hormone Antagonist Huddle Card Sexuality Huddle Card American Cancer Society prostate cancer page National Comprehensive Cancer Network homepage To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode "I think it's important to note that urologists are usually the ones that are doing the diagnosis of prostate cancer and really start that staging of prostate cancer. And the medical oncologists usually are not consulted until the patient is at a greater stage of prostate cancer. I find that it's important to state because a lot of our patients start with urologists, and by the time they've come to us, they're a lot further staged. But once a prostate cancer has been suspected, the patient needs to be staged for the extent of disease prior to that physician making any treatment recommendations. The staging includes doing a core biopsy of the prostate gland. During this core biopsy, they take multiple different cores at different areas throughout the prostate to really look to see what the cancer looks like." TS 1:46 "[For] the very low- and low-risk group, the most common [treatment] is active surveillance. ... Patients can be offered other options such as radiation therapy or surgery if they're not happy with active surveillance. ... The intermediate-risk group has favorable and unfavorable [status]. So, if they're a favorable, their Gleason score is usually a bit lower, things are not as advanced. These patients are offered active surveillance and then either radical prostatectomy with possible removal of lymph nodes or radiation—external beam or brachytherapy. If a patient has unfavorable intermediate risk, they are offered radical prostatectomy with removal of lymph nodes, external radiation therapy plus hormone therapy, or external radiation with brachytherapy. All three of these are offered to patients, although most frequently we see that our patients are taken in for radical prostatectomy. For the high- or very high-risk [group], patients are offered radiation therapy with hormone therapy, typically for one to three years. And then radical prostatectomy with removal of lymph nodes could also be offered for those patients." TS 7:55 "Radiation can play a role in any risk group depending on the patient's preference. ... The types of radiation that we use are external beam, brachytherapy, which is an internal therapy, and radiopharmaceuticals, [which are] more for advanced cancer, but we are seeing them used in prostate [cancer] as well. External beam radiation focuses on the tumor and any metastasis we may have with the tumor. It can be used in any risk [group] and for recurrence if radiation has not been done previously. If a patient has already been radiated to the pelvic area or to the prostate, radiation is usually not given again because we don't want to damage the patient any further. Brachytherapy is when we put radioactive pellets directly into the prostate. For early-stage prostate cancer, this can be given alone. And for patients who have a higher risk of the cancer growing outside the prostate, it can be given in combination with external beam radiation. It's important to note with brachytherapy, it cannot be used on patients who've had a transurethral resection of the prostate or any urinary problems. And if the patient has a large prostate, they may have to be on some hormone therapy prior to brachytherapy, just to shrink that prostate down a little bit to get the best effect. ... Radiopharmaceuticals treat the prostate-specific membrane antigen." TS 11:05 "The side effects of surgery are usually what deter the patient from wanting surgery. The first one is urinary incontinence. A lot of times, a patient has a lot of urinary incontinence after they have surgery. The other one is erectile dysfunction. A lot of patients may not want to have erectile dysfunction. Or, if having an erection is important to the patient, they may not want to have surgery to damage that. In this day and age, physicians have gotten a lot better at doing nerve-sparing surgeries. And so they really do try to do that so that the patient does not have any issues with erectile dysfunction after surgery. But [depending on] the extent of the cancer where it's growing around those nerves or there are other things going on, they may not be able to save those nerves." TS 15:26 "Luteinizing hormone-releasing hormone, or LHRH antagonists or analogs, lower the amount of testosterone made by the testicles. We're trying to stop those hormones from growing to prevent the cancer. ... When we lower the testosterone very quickly, there can be a lot more side effects. But if we lower it a little bit less, we can maybe help prevent some of them. The side effects are important. When I was writing this up, I was thinking, 'Okay, this is basically what women go through when they go through menopause.' We're decreasing the estrogen. We're now decreasing the testosterone. So, the patients can have reduced or absent sexual desire, they can have gynecomastia, hot flashes, osteopenia, anemia, decreased mental sharpness, loss of muscle mass, weight gain, and fatigue." TS 17:50 "What we all need to remember is that no patient is the same. They may not have the same goals for treatment as the physicians or the nurses want for the patient. We talked about surgery as the most common treatment modality that's presented to patients, but it's not necessarily the option that they want. It's really important for healthcare professionals to understand their biases before talking to the patients and the family. It's also important to remember that not all patients are in heterosexual relationships, so we need to explain recovery after treatment to meet the needs of our patients and their sexual relationships, which is sometimes hard for us. But remembering that—especially gay men—they may not have the same recovery period as a heterosexual male when it comes to sexual relationships. So, making sure that we have those frank conversations with our patients and really check our biases prior to going in and talking with them." TS 27:16

In this episode of The Performance Medicine Show, Andy Rogers, PA-C answers YOUR health and wellness questions!What did you think of this episode of the podcast? Let us know by leaving a review!Connect with Performance Medicine!Check out our new online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PMedicine⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@PerformancemedicineTN⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Performance Medicine

In this heartfelt episode of 20-Minute Health Talk, host Sandra Lindsay delves into the emotional journey of prostate cancer from the unique perspectives of supportive partners. Joining her are two remarkable women, Mary Hillery and Tamara Houston, who share their experiences as caregivers alongside their husbands, prostate cancer survivors Tony Hillery and former New York Knicks player Allan Houston. Mary Hillery, a human resources expert, offers insights on resilience and caregiving. Tamara Houston, an educator and advocate for youth empowerment, speaks on the power of faith and familial support in challenging times. Tune in to hear their powerful testimonies of love, partnership, and unwavering strength. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 28 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit the health system's job portal and explore our many opportunities.  

Did you know that dogs and most animals almost never get prostate cancer, yet humans do? In this episode, Dr. Stephen Petteruti digs into one of medicine's biggest mysteries and exposes how our current approach may be creating a “pathological tsunami” that leads to more invasive tests and more expensive, patented treatments. From animal biology to overlooked medical history, he breaks down why prostate cancer is nearly unique to humans, the hidden dangers behind routine biopsies, and how conventional medicine may be contributing to the very problem it's trying to solve. If you care about men's longevity, medical truth, or smarter, safer approaches to prostate health, this episode will challenge what you think you know. Tune in to this week's episode of Intellectual Medicine: Can Dogs Get Prostate Cancer? What It Teaches Us About Men's Health.Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives. Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home  #ProstateHealth #CancerResearch #BiopsyRisksDisclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Full article: PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics—A Systematic Review and Meta-Analysis Research quality can influence the results of studies evaluating PI-RADS performance. Tobi Folami, MD, discusses this AJR article by Nedelcu et al. reporting a meta-analysis of PI-RADS v2.1 performance, with attention to the impact of study quality.

About one in eight men will be diagnosed with prostate cancer in their lifetime. What are some diet and lifestyle solutions?